Frontlight ResearchEarly access
Not yet recruitingPhase 3
Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 3
- People taking part
- 60 people, planned
- Started
- 20 Sept 2025
- Planned end
- 20 Sept 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- propranolol
- normal saline IV
- Record updated
- 11 March 2025
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Patients aged between 18and 65 years old
- Patients who have Severe traumatic brain injury
- Glascow outcome scale ≤ 8
Who cannot take part
- Patients have pre-existing heart disease
- If there are contraindications to β blocker
- penetrating traumatic brain injury
- pre-injury brain dysfunction
- β-blocker or α2-agonist use before trauma
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The role of nonselective beta adrenergic blocker as antistress agent in severe traumatic brain injury
The 2 groups in the trial
- Propranolol groupTreatment being tested
This group Will receive propranolol intravenously at a dose of 1 mg every 6 h for 7 days.
Treatment: propranolol
- normal saline IV groupPlacebo, for comparison
This group Will receive 1ml of sterile 0.9% normal saline IV every 6 hours for 7 days
Treatment: normal saline IV
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Role of Non-Selective Beta-Adrenergic Blocker in Severe Traumatic Brain Injury
- Criteria questions
- Built from NCT06870370, who can take part
- Record updated
- 11 March 2025